Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Jaywant A, Vanderlind WM, Alexopoulos GS, Fridman CB, Perlis RH, Gunning FM. Neuropsychopharmacology. 2021:1–6. https://doi.org/10.1038/s41386-021-00978-8. Epub ahead of print.
Batty GD, Deary IJ, Luciano M, Altschul DM, Kivimäki M, Gale CR. Brain Behav Immun. 2020;89:569–78.
Mcloughlin BC, Miles A, Webb TE, Knopp P, Eyres C, Fabbri A, et al. Eur Geriatr Med. 2020;11:857–62.
Alonso-Lana S, Marquié M, Ruiz A, Boada M. Front Aging Neurosci. 2020;12:588872.
Author information
Authors and Affiliations
Contributions
KEB drafted the original manuscript; CEM edited and critically reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Burdick, K.E., Millett, C.E. The impact of COVID-19 on cognition in severe cases highlights the need for comprehensive neuropsychological evaluations in all survivors. Neuropsychopharmacol. 46, 2225 (2021). https://doi.org/10.1038/s41386-021-00995-7
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41386-021-00995-7
This article is cited by
-
Cell-specific transcriptional signatures of vascular cells in Alzheimer’s disease: perspectives, pathways, and therapeutic directions
Molecular Neurodegeneration (2025)
-
Cognitive function in recovered COVID-19 Lebanese patients with schizophrenia
Annals of General Psychiatry (2023)
-
Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort
Journal of Neurology (2023)
-
Management of post-acute COVID-19 patients in geriatric rehabilitation: EuGMS guidance
European Geriatric Medicine (2022)